Testing Ultraprocessed Food Labels in Chile

NCT ID: NCT06842680

Last Updated: 2025-09-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

3645 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-14

Study Completion Date

2025-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this experiment is to examine the effects of a warning label signaling that a product is ultraprocessed among a sample of Chilean parents. The main questions this experiment aims to answer are:

Do ultraprocessed warning labels on their own impact product purchase intentions?

Do ultraprocessed warning labels impact product purchase intentions in the presence of nutrient warning labels?

Do ultraprocessed warning labels help more consumers identify ultraprocessed foods?

Participants will be randomly assigned to a control arm or an ultraprocessed warning label arm. In both arms, products will carry nutrient warning labels, which are Chile's current policy. Participants will see three similar products, all of which will be ultraprocessed: one not high in any nutrients of concern, one high in sodium, and one high in sodium and saturated fat. For each product, participants will rate their purchase intentions and indicate whether they believe the product to be ultraprocessed. Researchers will compare results across arms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will complete an online randomized experiment programmed in Qualtrics. After providing informed consent, participants will be randomly assigned to one of two arms: control (i.e., no ultraprocessed warning label) arm or ultraprocessed warning label arm. In both arms, products will carry nutrient warning labels, which are Chile's current policy.

In random order, participants will see three similar mock bags of potato chips. All products seen will be ultraprocessed, and thus carry an ultraprocessed warning label in the ultraprocessed warning label arm. Additionally, one of the products will not be high in any nutrients of concern, one product will be high in sodium, and one product will be high in sodium and saturated fat. For each product, participants will rate their purchase intentions, perceived healthfulness, and indicate whether they believe the product to be ultraprocessed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diet, Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Group Type ACTIVE_COMPARATOR

Control

Intervention Type BEHAVIORAL

Products do not carry ultraprocessed warning label. To match the current Chilean legislation, products carry octagonal nutrient labels when applicable.

Ultraprocessed warning label

Group Type EXPERIMENTAL

Ultraprocessed warning label

Intervention Type BEHAVIORAL

Products carry ultraprocessed warning label. To match the current Chilean legislation, products carry octagonal nutrient labels when applicable.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Control

Products do not carry ultraprocessed warning label. To match the current Chilean legislation, products carry octagonal nutrient labels when applicable.

Intervention Type BEHAVIORAL

Ultraprocessed warning label

Products carry ultraprocessed warning label. To match the current Chilean legislation, products carry octagonal nutrient labels when applicable.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older
* Parent or guardian of child between 2-14 years old who has never been diagnosed with diabetes, high blood sugar, pre-diabetes or insulin resistance
* Residing in Chile

Exclusion Criteria

* Less than 18 years old
* Not parent or guardian of child between 2-14 years old who has never been diagnosed with diabetes, high blood sugar, pre-diabetes or insulin resistance
* Not residing in Chile
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Instituto de Nutrición y Tecnología de los Alimentos

OTHER

Sponsor Role collaborator

Bloomberg Philanthropies

OTHER

Sponsor Role collaborator

University of North Carolina, Chapel Hill

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aline D'Angelo Campos, MPP

Role: PRINCIPAL_INVESTIGATOR

University of North Carolina, Chapel Hill

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of North Carolina at Chapel Hill's Gillings School of Global Public Health

Chapel Hill, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

24-2896b

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.